Labeler
Astellas Pharma US, Inc. NDC Codes
Astellas Pharma US, Inc. lists 29 finished drug products in the FDA NDC Directory under NDC labeler codes 0469, 82829.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Prograf, Xtandi, Veozah, Cresemba, Myrbetriq, Astagraf XL, Vyloy, Izervay, Xospata, Lexiscan, Mycamine
- Active ingredients
- Tacrolimus, Enzalutamide, Fezolinetant, Isavuconazonium sulfate, Mirabegron, Zolbetuximab, Avacincaptad pegol sodium, Gilteritinib fumarate, Regadenoson, Micafungin sodium
- NDC labeler codes
- 0469, 82829
- Strengths
- Enzalutamide 40 mg/1; Fezolinetant 45 mg/1; Tacrolimus 1 mg/1; Zolbetuximab 20 mg/mL; Tacrolimus 5 mg/1; Tacrolimus .5 mg/1; Avacincaptad pegol sodium 20 mg/mL; Isavuconazonium sulfate 40 mg/1; Mirabegron 8 mg/mL; Enzalutamide 80 mg/1; Gilteritinib fumarate 40 mg/1; Tacrolimus .2 mg/1; Isavuconazonium sulfate 100 mg/1; Isavuconazonium sulfate 40 mg/mL; Mirabegron 25 mg/1; Mirabegron 50 mg/1; Regadenoson .08 mg/mL; Micafungin sodium 10 mg/mL; Tacrolimus 5 mg/mL
- Dosage forms
- Capsule, Tablet, Tablet, Film coated, Capsule, Coated, Extended release, Capsule, Gelatin coated, Injection, Powder, For suspension, Granule, For suspension, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Extended release, Injection, Solution, Injection, Granule, For suspension, Extended release
- Routes
- Oral, Intravenous, Intravitreal
- Drug classes (FDA established)
- Calcineurin Inhibitor Immunosuppressant, Androgen Receptor Inhibitor, Neurokinin 3 Receptor Antagonist, Azole Antifungal, beta3-Adrenergic Agonist, Claudin 18.2-directed Cytolytic Antibody, Complement Inhibitor, Adenosine Receptor Agonist, Echinocandin Antifungal
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 36
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Vyloyzolbetuximab | Zolbetuximab 20 mg/mL | Injection, Powder, For suspensionIntravenous | 0469-4425 | 00469-4425-30 | — |
| Vyloyzolbetuximab | Zolbetuximab 20 mg/mL | Injection, Powder, For suspensionIntravenous | 0469-3425 | 00469-3425-10 | — |
| Izervayavacincaptad pegol | Avacincaptad pegol sodium 20 mg/mL | InjectionIntravitreal | 82829-002 | 82829-0002-0182829-0002-99 | — |
| Veozahfezolinetant | Fezolinetant 45 mg/1 | Tablet, Film coatedOral | 0469-2460 | 00469-2460-28 | — |
| Veozahfezolinetant | Fezolinetant 45 mg/1 | Tablet, Film coatedOral | 0469-2660 | 00469-2660-3000469-2660-90 | — |
| Veozahfezolinetant | Fezolinetant 45 mg/1 | Tablet, Film coatedOral | 0469-2760 | 00469-2760-28 | — |
| Cresembaisavuconazonium sulfate | Isavuconazonium sulfate 40 mg/1 | CapsuleOral | 0469-2860 | 00469-2860-35 | — |
| Myrbetriqmirabegron | Mirabegron 8 mg/mL | Granule, For suspension, Extended releaseOral | 0469-5020 | 00469-5020-99 | — |
| Xtandienzalutamide | Enzalutamide 80 mg/1 | TabletOral | 0469-0725 | 00469-0725-60 | — |
| Xtandienzalutamide | Enzalutamide 40 mg/1 | TabletOral | 0469-1725 | 00469-1725-56 | — |
| Xtandienzalutamide | Enzalutamide 40 mg/1 | TabletOral | 0469-0625 | 00469-0625-99 | — |
| Xospatagilteritinib | Gilteritinib fumarate 40 mg/1 | TabletOral | 0469-1425 | 00469-1425-2100469-1425-90 | — |
| Prograftacrolimus | Tacrolimus .2 mg/1 | Granule, For suspensionOral | 0469-1230 | 00469-1230-50 | — |
| Prograftacrolimus | Tacrolimus 1 mg/1 | Granule, For suspensionOral | 0469-1330 | 00469-1330-50 | — |
| Cresembaisavuconazonium sulfate | Isavuconazonium sulfate 100 mg/1 | CapsuleOral | 0469-0520 | 00469-0520-02 | — |
| Cresembaisavuconazonium sulfate | Isavuconazonium sulfate 40 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0469-0420 | 00469-0420-01 | — |
| Astagraf XLtacrolimus extended-release capsules | Tacrolimus 1 mg/1 | Capsule, Coated, Extended releaseOral | 0469-0677 | 00469-0677-73 | — |
| Astagraf XLtacrolimus extended-release capsules | Tacrolimus 5 mg/1 | Capsule, Coated, Extended releaseOral | 0469-0687 | 00469-0687-73 | — |
| Astagraf XLtacrolimus extended-release capsules | Tacrolimus .5 mg/1 | Capsule, Coated, Extended releaseOral | 0469-0647 | 00469-0647-73 | — |
| Xtandienzalutamide | Enzalutamide 40 mg/1 | CapsuleOral | 0469-1125 | 00469-1125-56 | — |
| Xtandienzalutamide | Enzalutamide 40 mg/1 | CapsuleOral | 0469-0125 | 00469-0125-99 | — |
| Myrbetriqmirabegron | Mirabegron 25 mg/1 | Tablet, Film coated, Extended releaseOral | 0469-2601 | 00469-2601-0700469-2601-3000469-2601-90 | — |
| Myrbetriqmirabegron | Mirabegron 50 mg/1 | Tablet, Film coated, Extended releaseOral | 0469-2602 | 00469-2602-0700469-2602-3000469-2602-90 | — |
| Lexiscanregadenoson | Regadenoson .08 mg/mL | Injection, SolutionIntravenous | 0469-6501 | 00469-6501-89 | — |
| Mycaminemicafungin sodium | Micafungin sodium 10 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0469-3250 | 00469-3250-10 | — |
| Prograftacrolimus | Tacrolimus .5 mg/1 | Capsule, Gelatin coatedOral | 0469-0607 | 00469-0607-73 | — |
| Prograftacrolimus | Tacrolimus 5 mg/mL | Injection, SolutionIntravenous | 0469-3016 | 00469-3016-01 | — |
| Prograftacrolimus | Tacrolimus 1 mg/1 | Capsule, Gelatin coatedOral | 0469-0617 | 00469-0617-73 | — |
| Prograftacrolimus | Tacrolimus 5 mg/1 | Capsule, Gelatin coatedOral | 0469-0657 | 00469-0657-73 | — |
Astellas Pharma US, Inc.: common questions
- What is Astellas Pharma US, Inc.'s NDC labeler code?
- 0469, 82829. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Astellas Pharma US, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.